katrina4384Feb 26, 20220 min readSage Therapeutics - The FDA has granted Fast Track Designation to SAGE-718.Updated: Mar 31, 2022
uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease
PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program
Comments